Navigation Links
Global Orphan Drug Market Future Outlook 2015-2020
Date:6/8/2015

DUBLIN, June 08, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/g8q842/global_orphan) has announced the addition of the "Global Orphan Drug Market Future Outlook 2020" report to their offering.

In recent years, several new rare diseases are being included in clinical trials for the development of orphan drug candidate. Oncology, Genetic diseases, Autoimmune, pulmonary disease, Central nervous system and others are main focus of orphan drug developers. All of these diseases have large patient base but their rare forms doesn't have suitable therapeutics which reflects the marketing potential of orphan drugs in these segments.

Out of these, oncology segment has got maximum attention followed by rare genetic disorders, neurological disorder and autoimmune disorders. In a bigger view, orphan drug segment is expected to grow several folds in coming years due to several favorable factors. Introduction of innovative technologies, favorable pricing, reimbursement, unmet medical necessities and strong clinical pipeline could be attributed as important factors responsible for their growth.

"Global Orphan Drug Market Future Outlook 2020" report highlights:

- Global Orphan Drug Market Overview
- Global Orphan Drug Market Segment Analysis
- FDA & EMA Regulation for Clinical Trials Orphan Designated Drugs
- Orphan Drug Designation Criteria & Reimbursement Policy by Region
- Comprehensive Insight on Global Orphan Drugs Clinical Pipeline & Patent Analysis by Company, Country, Indication & Phase
- Global Orphan Drugs Clinical Pipeline: 697 Drugs
- Majority Orphan Drugs in Phase-II Trials: 249 Drugs
- Marketed Orphan Drugs: 274 Drugs

Key Topics Covered:

1. Introduction to Orphan Drug

2. Favorable Market Dynamics for Orphan Drugs Commercialization

3. Global Orphan Drug Market Overview

4. Global Orphan Drug Market Segment Analysis

5. Global Orphan Drug Clinical Pipeline Overview

6. US Orphan Drug Market Overview

7. Europe Orphan Drug Market Overview

8. Asia Orphan Drug Market Overview

9. FDA Regulation for Clinical Trials Orphan Designated Drugs

10. EMA Regulations for Clinical Trials of Orphan Designated Drugs

11. Asian Regulations for Clinical Trials of Orphan Designated Drugs

12. Global Orphan Drugs Clinical Pipeline Insight & Patent Analysis by Company, Country, Indication & Phase

13. Marketed Orphan Drugs Clinical Insight & Patent Analysis by Company, Country & Indication

14. Discontinued & Suspended Orphan Drugs in Clinical Trials

15. Competitive Landscape

- AOP Orphan
- Agenus
- Alexion
- Biogen Idec
- Bristol Myers Squibb
- Celgene
- Eli Lilly
- Genethon
- Genzyme Corporation
- Glaxosmithkline
- Merck
- Novartis Pharmaceuticals
- Orphan Europe
- Pfizer
- Prosensa
- Rare Disease Therapeutics
- Roche
- Sanofi
- Shire
- Teva Pharmaceutical

For more information visit http://www.researchandmarkets.com/research/g8q842/global_orphan

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Streptavidin (CAS 9013-20-1): Market Research Report 2015
2. AbbVie to Present at Goldman Sachs 36th Annual Global Healthcare Conference
3. Global Healthcare Financial Analytics Market 2015 - Growth, Trends & Forecast To 2020
4. Quest Diagnostics to Speak at the Goldman Sachs 36th Annual Global Healthcare Conference
5. Isis Pharmaceuticals to Present at the Goldman Sachs 36th Annual Global Healthcare Conference
6. Global Halogen Surgical Light Industry Report 2015
7. Global Electric Surgical Liposuction Pump Industry Report 2015
8. Global Surgical Incision Closures Industry
9. Global Blood Processing Supplies and Equipment Industry
10. Elastomers: Applications and Global Markets
11. Global Laboratory Centrifuges Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2019)... , ... March 25, 2019 , ... A March 1 article on CBS ... of social media but also in an effort to stand out in a competitive job ... surgery in order to gain any advantage possible in the workforce against their peers, as ...
(Date:3/25/2019)... ... 2019 , ... Alyfe Wellbeing Strategies announced today ... position of chief operating officer and Kris Zitzmann to vice president of strategic ... recognized leaders in the workplace health and wellbeing industry and previously held executive-level ...
(Date:3/25/2019)... (PRWEB) , ... March 25, 2019 , ... Shady ... welcome Dr. Melanie Ochalski to the Pennsylvania medical team. Dr. Ochalski is ... 283 and near the Shoppes at Belmont Town Center. The Lancaster, PA location is ...
Breaking Medicine Technology:
(Date:3/24/2019)... ... March 24, 2019 , ... U-Lace No-Tie Sneaker ... as a suicide prevention safety product for the Behavioral Healthcare industry this spring ... Ligature strangulation events have been on the rise in mental health facilities. U-Lace ...
(Date:3/23/2019)... ... March 22, 2019 , ... In 2019, Excelsior ... a coveted designation granted to select schools by the National League for Nursing. ... the designation to schools of distinction after a rigorous selection process. To earn ...
(Date:3/23/2019)... ... March 22, 2019 , ... The Society for Immunotherapy of ... Distinguished Professor of Immunology and Surgery and Founding Chair of the university’s Department ... Award and Lectureship, the society’s highest honor. , Dr. Finn, whose basic and ...
(Date:3/20/2019)... (PRWEB) , ... March 20, 2019 , ... American Family ... partnered with ApplePie Capital to offer new and existing franchisees access to up to ... Over the past 36 years, AFC has pioneered the concept of urgent care and ...
(Date:3/20/2019)... , ... March 20, 2019 , ... In the early-morning ... the staff at Chapel of the Flowers had a very special project that benefited ... world participated in the annual Walk-For-Wishes for Southern Nevada. , Chapel of the ...
Breaking Medicine News(10 mins):